SCHEMBL19796232

SCHEMBL19796232

COC(=O)Cc1cc(Br)ccc1OCCOC1CCCCO1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.42
MEN1 O00255 4/20 0.42
MAPK1 P28482 1/20 0.39
RXFP1 Q9HBX9 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
CCR5 P51681 1/20 0.37
KDM4C Q9H3R0 1/20 0.37
CREBBP Q92793 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
PKM P14618 1/20 0.36
LMNA P02545 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
PTGDR Q13258 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22031112 0.86 MEN1 (0.42) KMT2AMEN1MAPK1NPC1RAB9A
SCHEMBL26104783 0.83 KMT2A (0.43) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL30362091 0.83 KMT2A (0.43) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL19624538 0.83 NPC1 (0.43) KMT2AMEN1MAPK1NPC1RAB9A
SCHEMBL19624541 0.82 KDM4C (0.42) KMT2AMEN1MAPK1NPC1RAB9A
SCHEMBL19304000 0.80 NPC1 (0.46) KMT2AMEN1RXFP1NPC1RAB9A
SCHEMBL19796211 0.76 KDM4C (0.40) KMT2AMEN1NPC1RAB9ANPY1R
SCHEMBL20906593 0.76 NPC1 (0.48) KMT2AMEN1NPC1RAB9ANPY1R
SCHEMBL1629524 0.75 S1PR4 (0.43) KMT2AMEN1NPC1RAB9ANPY1R
SCHEMBL247949 0.75 KDM4C (0.41) KMT2AMEN1NPC1RAB9ANPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 KMT2A 3392/4885MEN1 1151/4885MAPK1 687/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.